Multicomponent smoking cessation treatment including mobile contingency management in homeless veterans

J Clin Psychiatry. 2015 Jul;76(7):959-64. doi: 10.4088/JCP.14m09053.

Abstract

Introduction: Smoking rates are 80% among persons who are homeless, and these smokers have decreased odds of quitting smoking. Little is known about relapse rates among homeless smokers. More information is needed regarding both quit rates and innovative methods to treat smoking cessation among homeless smokers. Web-based contingency management (CM) approaches have been found helpful in reducing smoking among other difficult-to-treat smoker populations but have been generally limited by the need for computers or frequent clinic-based carbon monoxide (CO) monitoring. This open pilot study builds on a web-based CM approach by evaluating a smartphone-based application for CM named mobile CM (mCM). The study was conducted from January 1, 2013-April 15, 2014.

Method: Following a 1-week training period, 20 homeless veteran smokers (≥ 10 cigarettes daily for 1 year or more and a CO baseline level ≥ 10 ppm) participated in a multicomponent smoking cessation intervention including 4 weeks of mCM. All smokers received 4 smoking cessation counseling sessions, nicotine replacement, and bupropion (if medically eligible). Participants could earn up to $815 ($480 for mCM, $100 for CO readings showing abstinence [ie, 6 ppm or less] at posttreatment and follow-up, and $35 for equipment return).

Results: Mean compensation for the mCM component was $286 of a possible $480. Video transmission compliance was high during the 1-week training (97%) and the 4-week treatment period (87%). Bioverified 7-day point prevalence abstinence was 50% at 4 weeks. Follow-up bioverified single assessment point prevalence abstinence was 55% at 3 months and 45% at 6 months.

Conclusions: Results of this open pilot study suggest that mCM may be a useful adjunctive smoking cessation treatment component for reducing smoking among homeless veterans.

Trial registration: ClinicalTrials.gov identifier: NCT01789710.

Publication types

  • Clinical Trial
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Aged
  • Bupropion / therapeutic use
  • Counseling
  • Dopamine Uptake Inhibitors / therapeutic use
  • Female
  • Follow-Up Studies
  • Humans
  • Ill-Housed Persons*
  • Male
  • Middle Aged
  • Mobile Applications*
  • Smoking Cessation / methods*
  • Tobacco Use Cessation Devices
  • Tobacco Use Disorder / drug therapy
  • Tobacco Use Disorder / therapy*
  • Treatment Outcome
  • Veterans*

Substances

  • Dopamine Uptake Inhibitors
  • Bupropion

Associated data

  • ClinicalTrials.gov/NCT01789710